White Ash Allergy Shots: Eastern US Gateway to Oleaceae SCIT
White ash allergy shots (SCIT) address the eastern US's hidden spring co-allergen — Fra e 1, ash's major protein, shares 88% sequence identity with olive's Ole e 1, meaning ash-anchored SCIT cross-protects the entire Oleaceae family. In Italy and France, ash causes 18–34% of spring allergies. No US-specific RCT exists, but the Niederberger 2002 cross-protection mechanism and EU-standardized ash extract (Hrabina 2007) provide a solid scientific foundation.
White Ash Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to white ash — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of white ash allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of white ash immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of white ash extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for white ash allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing white ash extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription white ash immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat white ash allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is White Ash?
The biology, taxonomy, and clinical fingerprint of White Ash — the foundation of how SCIT targets it.
Fraxinus americana male catkins releasing pollen March–April in the eastern United States. The ~22 μm tricolporate pollen grain is a major secondary spring aeroallergen from Maine to Texas.
- Scientific name
- Fraxinus americana
- Family
- OleaceaeOlive family
- Type
- Spring tree pollen
- Native to
- Eastern United States (Maine to Florida, west to Great Plains)
- Allergen proteins
- Fra e 1 (major) — Ole e 1-like family, ~20 kDa; shares 88% sequence identity with Ole e 1 (olive), 91% with Lig v 1 (privet), 82% with Syr v 1 (lilac) — Niederberger 2002Note: WHO/IUIS lists Fra e 1 for European ash (Fraxinus excelsior); US Fraxinus americana expresses homologous proteins but is not separately characterized in WHO/IUIS as of 2025 (allergen.org)
- Particle size
- ~22 μm, tricolporate
- Avoidance difficulty
- Very difficult
How White Ash Allergy Presents
Symptoms by body system — useful for distinguishing White Ash sensitivity from overlapping allergies and infections.
Respiratory
- Nasal congestion and rhinorrhea beginning March when ash catkins dehisce
- Sneezing triggered by outdoor exposure during peak pollen release
- Asthma exacerbations in sensitized patients during the March–April window
- Postnasal drip and chronic cough overlapping with oak season
Ocular
- Bilateral eye itching and watering (allergic conjunctivitis) during ash pollen release
- Eyelid swelling and periorbital edema on high-count days
- Persistent eye redness extending into the oak-season overlap
Dermal
- Contact urticaria from handling ash bark or foliage
- Generalized itching during high-pollen days in highly sensitized individuals
- Eczema flares in atopic patients coinciding with March–April tree pollen peak
Systemic
- Fatigue from sustained high-pollen exposure across the spring season
- Sleep disruption from nocturnal nasal blockage
- Headache from sinus pressure during peak ash count days
- Reduced productivity during the March–May combined tree-pollen season
Ash sensitization is one of the most under-recognized drivers of spring allergy in the Mid-Atlantic and Southeast. Because Fra e 1 and Ole e 1 overlap so heavily in sequence, treating ash often resolves symptoms that patients attributed entirely to oak — and confirms Oleaceae sensitization that carries cross-protection across the whole family.
When & Where White Ash Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: mid-March through mid-April in the eastern US; overlaps with oak and maple seasons· ~6–8 weeks of significant pollen exposure; season has shifted earlier per Anderegg et al. PNAS 2021
US Exposure Map
10 high-intensity statesWhat White Ash Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
White ash's major allergen Fra e 1 belongs to the Ole e 1-like protein family — the same structural family as olive's Ole e 1 (88% identity), privet's Lig v 1 (91% identity), and lilac's Syr v 1 (82% identity). Ash-sensitized patients are nearly universally cross-reactive with the full Oleaceae family.
Fra e 1 shares 91% identity with Lig v 1 (privet) — the highest intra-Oleaceae cross-reactivity (Niederberger 2002)
Is SCIT Right for Your White Ash Allergy?
Answer five questions to assess whether white ash SCIT is right for your spring allergy profile.
How severe are your early spring (March–April) allergy symptoms in the eastern US?
The White Ash SCIT Protocol
White ash SCIT uses a non-standardized extract anchored to Fra e 1, the Ole e 1-like major allergen. Build-up typically begins in late summer or fall to reach maintenance before March ash season.
Incremental dose escalation from the most dilute vial. Your allergist sets the starting dose based on skin-test or specific IgE results. Because ash, olive, and privet share Ole e 1-like proteins, your allergist may combine ash with olive extract in a single vial. With at-home SCIT through Curex, the first injection and every dose increase are supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand and a 30-minute self-observation after each injection.
Monthly maintenance injections sustain Fra e 1-specific tolerance, with immunologic markers (rising IgG4, declining IgE) typically shifting over 12–18 months. The Oleaceae cross-protection documented by Niederberger 2002 means that ash maintenance cross-protects olive and privet exposures.
After completing 3–5 years of maintenance, your allergist assesses lasting tolerance. Many patients sustain reduced spring symptoms for several years post-SCIT, though individual durability varies.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for White Ash SCIT
White ash SCIT is supported by cross-species Oleaceae evidence rather than a species-specific US RCT. The Niederberger 2002 mechanism and EU ash extract development (Hrabina 2007) form the scientific foundation; no US randomized trial specific to white ash exists as of 2025.
- Fra e 1 / Ole e 1 sequence identity (cross-protection basis)88%Niederberger V, et al. Clin Exp Allergy 2002;32:933–941 — olive AIT cross-protects ash and vice versa via shared Ole e 1-like protein family
- Fra e 1 / Lig v 1 identity (family cross-protection)91%Niederberger V, et al. Clin Exp Allergy 2002;32:933–941 — 91% identity establishes full Oleaceae cross-protection
- EU standardized ash extract skin-test reactivity65%Hrabina M, et al. Int Arch Allergy Immunol 2007;142:13–21 — EU ash extract standardization demonstrating robust diagnostic reagent quality
No US randomized controlled trial specific to white ash SCIT has been published as of 2025. Clinical use is anchored to the Oleaceae cross-protection mechanism documented by Niederberger 2002, the EU ash extract standardization (Hrabina 2007), and the AVANZ olive trial (Pareja 2015) — all of which support ash-anchored SCIT as a scientifically rational intervention for eastern US patients with Fra e 1 sensitization. A board-certified allergist should confirm Oleaceae sensitization before prescribing.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
White Ash SCIT Side Effects
White ash SCIT carries the standard inhalant immunotherapy side-effect profile — local injection-site reactions are expected and common during build-up, while serious systemic reactions are rare under proper observation protocols.
Local reactions
4 documentedSystemic reactions
4 documentedWhite ash SCIT has traditionally been administered in an allergy office equipped with epinephrine and resuscitation equipment; for eligible maintenance patients, Curex makes safe at-home self-administration possible with a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose and every dose change supervised live over Zoom by a board-certified allergist. A 30-minute self-observation follows every dose and captures the vast majority of systemic reactions. No fatalities from SCIT have been reported in the US in the past decade under proper observation protocols (Greenhawt et al., Ann Allergy Asthma Immunol 2023).
SCIT vs Alternatives for White Ash
Eastern US patients with white ash allergy have four main options: SCIT (best evidence for Oleaceae family cross-protection), at-home SLIT drops, avoidance, or daily antihistamines and nasal steroids.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Best for moderate-severe ash AR; Oleaceae family cross-protection via Niederberger 2002 | Emerging evidence; Ole e 1-based drops show immunologic activity in Oleaceae | Difficult during March–April peak in eastern US; pollen load very high | Good for mild-moderate; may be insufficient at peak tree-pollen counts |
| 5-yr cost | $3,500–$15,000 over 5 years | $39–$150/month depending on provider | Low direct cost; high lifestyle burden | $300–$1,200/year for prescriptions |
| Duration | 3–5 years weekly then monthly | 3–5 years daily drops | Permanent lifestyle restriction | Lifelong daily use |
| Convenience | Weekly at-home self-injection for ~6 months with Curex; first dose and dose changes supervised live over Zoom | At-home; no clinic visits needed | HEPA filtration indoors helps; outdoor avoidance during spring impractical | Convenient daily pills and nasal sprays |
| Safety | Excellent; rare systemic reactions, with a sterile-compounded serum, a prescribed epinephrine auto-injector on hand, and live Zoom supervision of every dose change | Lower systemic reaction risk than SCIT | No treatment risk; no disease modification | Well-established safety profile |
| Lasting effect | Years of lasting benefit after completing course | Duration of benefit still being studied | No lasting benefit; symptoms return with every spring | No lasting benefit; symptoms return when medications stop |
SCITBest
SLIT
Avoidance
Medications
For eastern US patients with moderate-to-severe ash sensitization who want broad Oleaceae cross-protection without lifelong daily medications, SCIT is the strongest evidence-based option — now available from Curex as a weekly at-home allergy shot at $129/month, with a serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first dose and every dose change supervised live over Zoom by a board-certified allergist. Sublingual drops remain a general allergy modality some providers offer for patients who prefer a needle-free option.
What White Ash SCIT Actually Costs
Most major US insurers cover white ash SCIT under standard allergy benefits when prescribed by a board-certified allergist. Out-of-pocket cost depends on your deductible, co-insurance percentage, and whether your provider is in-network. Pre-authorization is typically required and can be facilitated by your allergist's office. Curex at-home IgE testing identifies specific white ash sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your white ash allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
White Ash SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
White ash and oak produce pollen during overlapping seasons (ash peaks March–April, oak typically April–May in the eastern US), but they belong to completely different botanical families with distinct allergen proteins. Ash is Oleaceae and its major allergen Fra e 1 shares 88% identity with olive's Ole e 1 — meaning ash-sensitized patients often cross-react with olive, privet, and Russian olive. Oak is Fagaceae and its major allergen Que a 1 belongs to the PR-10 family, cross-reacting with birch and hazel instead. A board-certified allergist uses component-resolved or species-specific skin testing to distinguish which tree is driving your early-spring symptoms, because the SCIT extracts and cross-protection patterns are completely different.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.